- Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
- Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
- Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
- Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Gaetan is Volition’s Chief Operating Officer and has been a valued member of Volition since 2014.
Over the past seven years, Gaetan has overseen the growth of the team in Belgium and the United States. During this time, our Belgian operations have expanded to a purpose-built research and development facility and a dedicated ‘Silver One’ manufacturing facility.
Gaetan now lives on the west coast of the United States, developing Volition’s Innovation and Clinical Operations teams based at our Innovation Hub in Carlsbad, San Diego County.
Watch Gaetan’s short video to find out more about his time at Volition.
I’m proud of the team we’ve built. It’s our force. They’ve been engaged since the beginning… people feel that working at Volition, they’ll be able to change things and be impactful.
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields